|
Originally published In Press as doi:10.1194/jlr.M600405-JLR200 on December 28, 2006
Originally published In Press as doi:10.1194/jlr.M600405-JLR200 on December 27, 2006
Papers In Press, published online ahead of print March 1, 2007
J. Lipid Res., doi:10.1194/jlr.M600405-JLR200
Journal of Lipid Research, Vol. 48, 674-682, March 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians
Wim A. van der Steeg1,*,
G. Kees Hovingh1,*,
Anke H. E. M. Klerkx*,
Barbara A. Hutten ,
Inge C. Nootenboom*,
Johannes H. M. Levels*,
Arie van Tol ,
Gees M. Dallinga-Thie ,
Aeilko H. Zwinderman ,
John J. P. Kastelein* and
Jan Albert Kuivenhoven2,*
* Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
Department of Cell Biology and Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
The online version of this article (available at http://www.jlr.org) contains supplemental data in the form of four tables and two figures.
Published, JLR Papers in Press, December 28, 2006.
1 W. A. van der Steeg and G. K. Hovingh contributed equally to this work.
2 To whom correspondence should be addressed. e-mail: j.a.kuivenhoven{at}amc.uva.nl
It is unclear whether cholesteryl ester transfer protein (CETP) contributes to high density lipoprotein cholesterol (HDL-C) levels in hyperalphalipoproteinemia (HALP) in Caucasians. Moreover, even less is known about the effects of hereditary CETP deficiency in non-Japanese. We studied 95 unrelated Caucasian individuals with HALP. No correlations between CETP concentration or activity and HDL-C were identified. Screening for CETP gene defects led to the identification of heterozygosity for a novel splice site mutation in one individual. Twenty-five heterozygotes for this mutation showed reduced CETP concentration (40%) and activity (50%) and a 35% increase of HDL-C compared with family controls. The heterozygotes presented with an isolated high HDL-C, whereas the remaining subjects exhibited a typical high HDL-C/low-triglyceride phenotype. The increase of HDL-C in the CETP-deficient heterozygotes was primarily attributable to increased high density lipoprotein containing apolipoprotein A-I and A-II (LpAI:AII) levels, contrasting with an increase in both high density lipoprotein containing apolipoprotein A-I only and LpAI:AII in the other group. This study suggests the absence of a relationship between CETP and HDL-C levels in Caucasians with HALP. The data furthermore indicate that genetic CETP deficiency is rare among Caucasians and that this disorder presents with a phenotype that is different from that of subjects with HALP who have no mutation in the CETP gene.
Supplementary key words deficiency mutation CETP-IVS7+1 Abbreviations: apoC-III, apolipoprotein C-III; BMI, body mass index; CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; HALP, hyperalphalipoproteinemia; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; LpAI, high density lipoprotein containing apolipoprotein A-I only; LpAI:AII, high density lipoprotein containing apolipoprotein A-I and A-II

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|